Get startedLog in
    Picture of Bridgebio Oncology Therapeutics logo

    BBOT — Bridgebio Oncology Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapSucker Stock
    All News

    Brief: Helix Acquisition Corp. II Retains More Than 60% Of Trust Account

    Picture of Bridgebio Oncology Therapeutics logoBridgebio Oncology Therapeutics
    06/08/2025 13:10
    Aug 6 (Reuters) - BridgeBio Pharma Inc BBIO.O:

HELIX ACQUISITION CORP. II RETAINS MORE THAN 60% OF TRUST ACCOUNT AFTER REDEMPTIONS IN CONNECTION WITH BUSINESS COMBINATION WITH BRIDGEBIO ONCOLOGY THERAPEUTICS

Source text: ID:nGNX4515PV

Further company coverage: BBIO.O

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Bridgebio Oncology Therapeutics

    See all news